IRIS
ALBISINNI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.464
EU - Europa 565
AS - Asia 384
SA - Sud America 9
AF - Africa 3
OC - Oceania 1
Totale 2.426
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.460
SG - Singapore 267
IT - Italia 232
IE - Irlanda 188
CN - Cina 93
GB - Regno Unito 39
DE - Germania 33
RU - Federazione Russa 25
FI - Finlandia 11
IN - India 11
UA - Ucraina 11
FR - Francia 6
SE - Svezia 6
AR - Argentina 5
BE - Belgio 4
CA - Canada 4
JP - Giappone 4
TR - Turchia 4
BR - Brasile 3
KR - Corea 3
SC - Seychelles 3
AT - Austria 2
ES - Italia 2
LU - Lussemburgo 2
BG - Bulgaria 1
CL - Cile 1
HK - Hong Kong 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 2.426
Salva come PNG Salva come JPEG
Città #
Singapore 244
Woodbridge 234
Wilmington 213
Dublin 187
Houston 184
Center 176
New York 94
St. George 85
Ashburn 79
Santa Clara 75
Beijing 66
Moscow 22
Milan 21
Rome 19
London 18
Mülheim 15
Zhengzhou 15
Seattle 11
Turin 11
Fairfield 10
Washington 10
Jacksonville 9
Pune 9
Lappeenranta 7
Bari 6
Shanghai 6
Caltana 5
Catania 5
Chandler 5
Chicago 5
Dearborn 5
Chiswick 4
Florence 4
Genoa 4
Kilburn 4
Medford 4
Naples 4
Nuremberg 4
Treviso 4
Berlin 3
Brescia 3
Marshall 3
Molfetta 3
Palermo 3
Prescot 3
Alcamo 2
Ann Arbor 2
Argenteau 2
Avellino 2
Boardman 2
Brussels 2
Buenos Aires 2
Cambridge 2
Cardano al Campo 2
Casavatore 2
Castegnero 2
Como 2
Council Bluffs 2
Drummondville 2
Enna 2
Ferrara 2
Frankfurt am Main 2
Gaggiano 2
Gaglianico 2
Helsinki 2
Innsbruck 2
Islington 2
Istanbul 2
Lawrence 2
Los Angeles 2
Luxembourg 2
Marseille 2
Massafra 2
Miami 2
Modena 2
New Bedfont 2
Osaka 2
Reggio Emilia 2
Rosignano Marittimo 2
San Lazzaro di Savena 2
Suffern 2
São Paulo 2
Torremaggiore 2
Tsukaguchicho 2
Verona 2
Vicenza 2
Wenzhou 2
Zaragoza 2
Afragola 1
Auckland 1
Bellegra 1
Bhopal 1
Billings 1
Boydton 1
Brasília 1
Cernusco sul Naviglio 1
Falconara Marittima 1
Falls Church 1
Fort Worth 1
Grenoble 1
Totale 1.999
Salva come PNG Salva come JPEG
Nome #
Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study 424
THE RELATION BETWEEN OBESITY AND PROSTATE CANCER: THE ROLE OF ABDOMINAL OBESITY AND BODY FRAME 363
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study 187
Antibodies targeting Prostate-Specific Membrane Antigen positive prostate cancer: from diagnostic imaging to theranostics 58
Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens 47
Clinical experience with 18F-JK-PSMA-7 when using a digital PET/CT 42
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial) 35
Laparoscopic treatment of pudendal nerve and artery entrapment improves erectile dysfunction in healthy young males 34
CAR-T Cell Therapy for Solid Tumors: Are we Still That Far? a Systematic Review of Literature 34
The train has already left the station: Analyzing the rise of PSMA PET/ CT as new standard for staging high risk prostate cancer 32
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches 32
Sexual dysfunction due to pudendal neuralgia: A systematic review 30
Robot-assisted radical cystectomy: towards a future of sexual-sparing surgery? 30
Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review 29
Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis 29
A systematic review of imaging-guided metastasis-directed therapy for oligorecurrent prostate cancer: Revolution or devolution? 28
Does antibiotic use explain the discrepancy of urolithiasis prevalence between countries? 28
Restaging transurethral resection in ta high-grade nonmuscle invasive bladder cancer: A systematic review 28
The grade of systemic inflammation, immune inhibition, and gut dysbiosis as prognostic factors for bladder cancer recurrence: a metabolomics approach 28
Prostate cancer, androgen deprivation, and risk of COVID-19 infection: A systematic review and meta-analysis|Cancer de Prostate, déprivation androgénique, et risques d'infection par la COVID-19: revue systématique et méta-analyse 28
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers 28
Management of chronic testicular pain due to thoracolumbar junction syndrome: A pilot study|La prise en charge de la douleur testiculaire chronique due a un syndrome de charniere thoraco-lombaire : étude pilote 27
Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate 27
To what extent should we trust statistics? 27
Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy 26
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines 26
Clinical effect of computed guided pudendal nerve block for patients with premature ejaculation: a pilot study 25
Cartography-based quality control of prostate cancer care: A necessary ground to targeted focal therapy 25
Antibody-Drug Conjugates in Prostate Cancer: Where Are we? 25
External Validation of a Multiparametric Magnetic Resonance Imaging–based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy 24
Anterior vs. retzius-sparing robotic assisted radical prostatectomy: can the approach really make a difference? 24
Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art 24
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis 24
Analysis of predictors of early trifecta achievement after robot-assisted radical prostatectomy for trainers and expert surgeons: the learning curve never ends 23
Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature 22
Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison 22
Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology—Young Academic Urologists: Urothelial Carcinoma Working Group 22
Focal therapy for prostate cancer: Making the punishment fit the crime|Thérapie focale pour le cancer de la prostate : une peine correspondante au crime 22
Urinary microbiota and prostatic diseases: the key for the lock? A systematic review 22
Prebiopsy 68Ga-PSMA PET imaging: can we improve the current diagnostic pathway for prostate cancer? 22
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort 21
Pentafecta after radical cystectomy: a necessary yet insufficient tool to describe surgical excellence 21
External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy 21
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication Index 21
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators 21
New Technologies for Kidney Surgery Planning 3D, Impression, Augmented Reality 3D, Reconstruction: Current Realities and Expectations 21
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study 21
Bladder cancer at the time of COVID-19 outbreak 20
Can the success with immunotherapy in metastatic urothelial bladder carcinoma be replicated in the neoadjuvant setting? 20
Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery 19
Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion 19
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis 19
Contemporary management of benign uretero-enteric strictures after cystectomy: a systematic review 19
Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: Results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology 19
Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature 19
Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis 18
Immune checkpoint inhibitors for BCG-resistant NMIBC: The dawn of a new era 18
Myths, Superstitions, and Popular Beliefs: Do They Still Impact Our Practice? 18
The role of perilesional and multiparametric resonance imaging-targeted biopsies to reduce the risk of upgrading at radical prostatectomy pathology: A retrospective monocentric study 18
Magnetic Resonance Imaging-Targeted Biopsy and Pretherapeutic Prostate Cancer Risk Assessment: a Systematic Review: Biopsie ciblée par Imagerie par résonance magnétique et évaluation pré-thérapeutique du risque de cancer de la prostate : revue systématique 18
COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor|COVID-19 et la susceptibilité du sexe masculin: le rôle de l'ACE2, la TMPRSS2 et le récepteur aux androgènes 18
Evidence-based medicine, the number ‘three’ and its multiples in urological clinical rules 17
Salvage Hemiablation High Intensity Focused Ultrasound for unilateral radio-recurrent prostate cancer|Hémiablation prostatique de sauvetage par des ultrasons focalisés à haute intensité pour des récidives unilatérales après radiothérapie prostatique 17
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic 17
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy 17
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications 17
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis 16
Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses 15
Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis 15
COVID-19 and BCG: where’s the challenge? 14
Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: Where do we stand? 14
Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group 13
Isolated non-ascitic peritoneal carcinomatosis after robotic radical prostatectomy for prostate cancer: A case report 13
Is there a role for repeating PSMA PET/CT after a negative scan in biochemical recurrent prostate cancer? 13
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging–targeted Biopsy? 7
Totale 2.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.418
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020178 0 0 17 19 17 21 20 21 15 18 13 17
2020/2021135 14 17 14 19 15 15 18 15 2 1 4 1
2021/202218 0 3 1 2 0 2 1 0 0 2 1 6
2022/2023806 2 1 1 1 2 628 80 5 14 7 44 21
2023/2024518 14 20 31 16 45 195 60 24 32 21 20 40
2024/2025584 38 372 174 0 0 0 0 0 0 0 0 0
Totale 2.647